283 related articles for article (PubMed ID: 30085294)
1. Systemic Toxicity of Smokeless Tobacco Products in Mice.
Malovichko MV; Zeller I; Krivokhizhina TV; Xie Z; Lorkiewicz P; Agarwal A; Wickramasinghe N; Sithu SD; Shah J; O'Toole T; Rai SN; Bhatnagar A; Conklin DJ; Srivastava S
Nicotine Tob Res; 2019 Jan; 21(1):101-110. PubMed ID: 30085294
[TBL] [Abstract][Full Text] [Related]
2. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
[TBL] [Abstract][Full Text] [Related]
3. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
Stepanov I; Jensen J; Hatsukami D; Hecht SS
Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
[TBL] [Abstract][Full Text] [Related]
4. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
[TBL] [Abstract][Full Text] [Related]
5. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
[TBL] [Abstract][Full Text] [Related]
6. Smokeless Tobacco Products (STPs) Harbour Bacterial Populations with Potential for Oral Carcinogenicity.
Monika S; Dineshkumar T; Priyadharini S; Niveditha T; Sk P; Rajkumar K
Asian Pac J Cancer Prev; 2020 Mar; 21(3):815-824. PubMed ID: 32212812
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
Lunell E; Fagerström K; Hughes J; Pendrill R
Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
[TBL] [Abstract][Full Text] [Related]
8. Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
Stepanov I; Biener L; Knezevich A; Nyman AL; Bliss R; Jensen J; Hecht SS; Hatsukami DK
Nicotine Tob Res; 2012 Mar; 14(3):274-81. PubMed ID: 22039075
[TBL] [Abstract][Full Text] [Related]
9. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Chronic Acrolein Inhalation Exposure in Mice: Implications for Tobacco Product-Induced Toxicity.
Conklin DJ; Malovichko MV; Zeller I; Das TP; Krivokhizhina TV; Lynch BH; Lorkiewicz P; Agarwal A; Wickramasinghe N; Haberzettl P; Sithu SD; Shah J; O'Toole TE; Rai SN; Bhatnagar A; Srivastava S
Toxicol Sci; 2017 Aug; 158(2):263-274. PubMed ID: 28482051
[TBL] [Abstract][Full Text] [Related]
11. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus).
Alizadehgharib S; Lehrkinder A; Alshabeeb A; Östberg AK; Lingström P
Eur J Oral Sci; 2022 Aug; 130(4):e12885. PubMed ID: 35853092
[TBL] [Abstract][Full Text] [Related]
12. Alteration in contractile G-protein coupled receptor expression by moist snuff and nicotine in rat cerebral arteries.
Sandhu H; Xu CB; Edvinsson L
Toxicol Appl Pharmacol; 2011 Apr; 252(2):138-49. PubMed ID: 21316381
[TBL] [Abstract][Full Text] [Related]
13. High-Intensity Sweeteners in Alternative Tobacco Products.
Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
[TBL] [Abstract][Full Text] [Related]
14. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
15. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features.
Cullen D; Keithly L; Kane K; Land T; Paskowsky M; Chen L; Hayes R; Li W
Tob Control; 2015 May; 24(3):256-62. PubMed ID: 24420311
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
17. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
Back S; Masser AE; Rutqvist LE; Lindholm J
BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
[TBL] [Abstract][Full Text] [Related]
18. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
Rahman Z; Dharani S; Khuroo T; Khan MA
AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
[TBL] [Abstract][Full Text] [Related]
19. Examining Market Trends in Smokeless Tobacco Sales in the United States: 2011-2019.
Delnevo CD; Hrywna M; Miller Lo EJ; Wackowski OA
Nicotine Tob Res; 2021 Aug; 23(8):1420-1424. PubMed ID: 33241271
[TBL] [Abstract][Full Text] [Related]
20. Determination of nicotine absorption from multiple tobacco products and nicotine gum.
Digard H; Proctor C; Kulasekaran A; Malmqvist U; Richter A
Nicotine Tob Res; 2013 Jan; 15(1):255-61. PubMed ID: 22585541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
